Is myelomeningocele a distinct subgroup within neuromuscular early-onset scoliosis (M-EOS)? A clinical and radiographic comparison after graduation from growing rod treatment.

IF 1.7 Q3 CLINICAL NEUROLOGY
Ataberk Beydemir, Rafik Ramazanov, Mehmet Berktas, Mehmet Ayvaz, Halil Gokhan Demirkiran, Muharrem Yazici
{"title":"Is myelomeningocele a distinct subgroup within neuromuscular early-onset scoliosis (M-EOS)? A clinical and radiographic comparison after graduation from growing rod treatment.","authors":"Ataberk Beydemir, Rafik Ramazanov, Mehmet Berktas, Mehmet Ayvaz, Halil Gokhan Demirkiran, Muharrem Yazici","doi":"10.1007/s43390-026-01558-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The aim was to compare clinical and radiographic outcomes between myelomeningocele (MMC) and other neuromuscular early-onset scoliosis (EOS) patients following graduation from growing rod treatment and to evaluate whether MMC should be considered a distinct subgroup within the classification of EOS.</p><p><strong>Methods: </strong>This single-center retrospective cohort study included 26 patients with neuromuscular EOS (10 with MMC, 16 with other neuromuscular etiologies) treated with traditional or magnetically controlled growing rods between 2004 and 2023, all of whom achieved graduation and had a minimum of 2-year of post-graduation follow-up. Demographic, clinical, radiographic, and complication data were analyzed. Complication burden was assessed using unplanned return to the operating room (UPROR), modified Clavien-Dindo-Sink grading, and negative binomial regression.</p><p><strong>Results: </strong>Wound-related complications were significantly more frequent in the MMC group (80.0% vs. 6.2%, p = 0.002). The MMC patients had a higher complication burden (mean 3.3 ± 2.3 vs. 0.9 ± 1.4, p = 0.003), more multiple reoperations (≥ 2 UPROR: 70.0% vs. 0.0%, p = 0.007), more severe complications (modified Clavien-Dindo-Sink grade 3b: 70.0% vs. 25.0%, p = 0.016), and a 3.52-fold higher overall complication rate (IRR = 3.52, 95% CI 1.63-10.80). Spinal growth and sagittal alignment were also significantly compromised in the MMC patients.</p><p><strong>Conclusion: </strong>MMC patients demonstrate a markedly distinct complication profile and clinical trajectory compared to other neuromuscular EOS patients, supporting consideration of MMC as a separate subgroup within EOS classification systems to improve risk stratification and guide individualized treatment. Even within the current framework, recognizing MMC through a diagnosis-specific modifier may offer a practical means of improving risk stratification without requiring structural reclassification.</p>","PeriodicalId":21796,"journal":{"name":"Spine deformity","volume":" ","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2026-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Spine deformity","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s43390-026-01558-w","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: The aim was to compare clinical and radiographic outcomes between myelomeningocele (MMC) and other neuromuscular early-onset scoliosis (EOS) patients following graduation from growing rod treatment and to evaluate whether MMC should be considered a distinct subgroup within the classification of EOS.

Methods: This single-center retrospective cohort study included 26 patients with neuromuscular EOS (10 with MMC, 16 with other neuromuscular etiologies) treated with traditional or magnetically controlled growing rods between 2004 and 2023, all of whom achieved graduation and had a minimum of 2-year of post-graduation follow-up. Demographic, clinical, radiographic, and complication data were analyzed. Complication burden was assessed using unplanned return to the operating room (UPROR), modified Clavien-Dindo-Sink grading, and negative binomial regression.

Results: Wound-related complications were significantly more frequent in the MMC group (80.0% vs. 6.2%, p = 0.002). The MMC patients had a higher complication burden (mean 3.3 ± 2.3 vs. 0.9 ± 1.4, p = 0.003), more multiple reoperations (≥ 2 UPROR: 70.0% vs. 0.0%, p = 0.007), more severe complications (modified Clavien-Dindo-Sink grade 3b: 70.0% vs. 25.0%, p = 0.016), and a 3.52-fold higher overall complication rate (IRR = 3.52, 95% CI 1.63-10.80). Spinal growth and sagittal alignment were also significantly compromised in the MMC patients.

Conclusion: MMC patients demonstrate a markedly distinct complication profile and clinical trajectory compared to other neuromuscular EOS patients, supporting consideration of MMC as a separate subgroup within EOS classification systems to improve risk stratification and guide individualized treatment. Even within the current framework, recognizing MMC through a diagnosis-specific modifier may offer a practical means of improving risk stratification without requiring structural reclassification.

脊髓脊膜膨出是神经肌肉性早发性脊柱侧凸(M-EOS)的一个独特亚群吗?生长棒治疗毕业后的临床与影像学比较。
目的:目的是比较脊髓脊膜膨出(MMC)和其他神经肌肉早发性脊柱侧凸(EOS)患者在生长棒治疗结束后的临床和影像学结果,并评估MMC是否应被视为EOS分类中的一个不同的亚组。方法:这项单中心回顾性队列研究纳入了2004年至2023年间接受传统或磁控生长棒治疗的26例神经肌肉型EOS患者(10例为MMC, 16例为其他神经肌肉病因),所有患者均已毕业,毕业后随访至少2年。对人口统计学、临床、影像学和并发症资料进行分析。采用非计划返回手术室(UPROR)、改进的Clavien-Dindo-Sink分级和负二项回归评估并发症负担。结果:MMC组伤口相关并发症发生率明显高于MMC组(80.0%比6.2%,p = 0.002)。MMC患者有更高的并发症负担(平均3.3±2.3比0.9±1.4,p = 0.003),更多的多次再手术(≥2 UPROR: 70.0%比0.0%,p = 0.007),更严重的并发症(改良Clavien-Dindo-Sink分级3b: 70.0%比25.0%,p = 0.016),总并发症发生率高3.52倍(IRR = 3.52, 95% CI 1.63-10.80)。MMC患者的脊柱生长和矢状位排列也明显受损。结论:与其他神经肌肉型EOS患者相比,MMC患者表现出明显不同的并发症特征和临床轨迹,支持将MMC作为EOS分类系统中单独的亚组,以改善风险分层和指导个体化治疗。即使在目前的框架内,通过诊断特异性修饰符识别MMC可能提供一种改进风险分层的实用方法,而不需要结构重新分类。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.20
自引率
18.80%
发文量
167
期刊介绍: Spine Deformity the official journal of the?Scoliosis Research Society is a peer-refereed publication to disseminate knowledge on basic science and clinical research into the?etiology?biomechanics?treatment?methods and outcomes of all types of?spinal deformities. The international members of the Editorial Board provide a worldwide perspective for the journal's area of interest.The?journal?will enhance the mission of the Society which is to foster the optimal care of all patients with?spine?deformities worldwide. Articles published in?Spine Deformity?are Medline indexed in PubMed.? The journal publishes original articles in the form of clinical and basic research. Spine Deformity will only publish studies that have institutional review board (IRB) or similar ethics committee approval for human and animal studies and have strictly observed these guidelines. The minimum follow-up period for follow-up clinical studies is 24 months.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书